Skip to main content

Pay Bill Portals

Our Tests
Our Services
- - Oncology
    - - SERVICES
        
        NateraCore Services
        
        Pharma Partnership
    - - FOR PATIENTS
        
        Schedule Session with Patient Coordinator
        
        Pricing and Billing Information
        
        Contact Us
    - - FOR CLINICIANS
        
        Schedule Session With Client Services
        
        Oncology Portal
        
        Order a Test Kit
        
        Contact Us
  - Organ Health
    - - SERVICES
        
        NateraCore Services
        
        ProReach
    - - FOR PATIENTS
        
        Schedule a Genetic Information Session
        
        Contact Us
    - - FOR CLINCIANS
        
        Organ Health Portal
        
        Contact Us
  - Women’s Health
    - - SERVICES
        
        NateraCore Services
        
        Constellation
    - - FOR PATIENTS
        
        Schedule a Genetic Information Session
        
        Pricing and Billing Information
        
        Women’s Health Portal
        
        Contact Us
    - - FOR CLINICIANS
        
        Order Tests and Track Status on NateraConnect
        
        View Patient Results on NateraConnect
        
        Contact Us
Patient Resources
- - Oncology
    - - LEARN
        
        Signatera
        Altera
        Empower
        View All Patient Resources
    - - EXISTING PATIENTS
        
        Schedule Blood Draw (Existing Patients)
        
        Schedule Session with Patient Coordinator
        
        Pricing and Billing Information
    - - CONNECT
        
        Contact Us
  - Organ Health
    - - LEARN
        
        Prospera
        Renasight
        View All Patient Resources
    - - EXISTING PATIENTS
        
        Schedule Blood Draw (Existing Patients)
        
        Schedule a Genetic Information Session
    - - CONNECT
        
        Contact Us
  - Women’s Health
    - - LEARN
        
        Horizon
        Panorama
        Empower
        Vistara
        Anora
        Spectrum
        View All Patient Resources
    - - EXISTING PATIENTS
        
        Schedule a Genetic Information Session
        
        Schedule Blood Draw (Existing Patients)
        
        Pricing and Billing Information
        
        Women’s Health Portal
    - - CONNECT
        
        Contact Us
Clinical Resources
- - Oncology
    - - CLINICAL RESOURCES
        
        Order Forms
        
        Signatera
        Signatera Publications
        Altera
        Empower
        View All Clinician Resources
    - - RESEARCH STUDIES
        
        Signatera Research Pipeline
        
        BESPOKE CRC
        
        BESPOKE IO
    - - CONNECT
        
        Oncology Portal
        
        Contact Us
  - Organ Health
    - - CLINICAL RESOURCES
        
        Organ Health Publications
        Prospera
        Renasight
        View All Clinician Resources
    - - RESEARCH STUDIES
        
        ProActive Study
        
        PEDAL Study
        
        Trifecta Study
        
        MOTR Study
    - - CONNECT
        
        Organ Health Portal
        
        Contact Us
  - Women’s Health
    - - CLINICAL RESOURCES
        
        Women’s Health Publications
        Horizon
        Panorama
        Empower
        Vistara
        Anora
        Spectrum
        Natera Academy Provider Education Hub
        View All Clinician Resources
    - - RESEARCH STUDIES
    - - CONNECT
        
        Contact Us
Company
Search for:
Pay Bill

Portals
Search for:

Natera, Inc.

- Altera
- Anora
- Empower
- Horizon
- Panorama
- Prospera
- Renasight
- Signatera
- Spectrum
- Vistara
- Blog
- Videos
- Brochure
- Whitepaper
- Manual
- Poster
- Report
- Study
- Webinars
- Natera Academy

Recent Searches

Home
Study
Personalized Detection of Circulating Tumor DNA Antedates Breast Cancer Metastatic Recurrence

Personalized Detection of Circulating Tumor DNA Antedates Breast Cancer Metastatic Recurrence

Previous Resource

Final results of neoadjuvant atezolizumab in cisplatin-ineligible patients with muscle-invasive urothelial cancer of the bladder

Szabados B, Kockx M, Assaf ZA, et al. European Urology.
Next Resource

Circulating tumor DNA in neoadjuvant treated breast cancer reflects response and survival.

Related Content

Stage III CRC Case Study

Read More
Circulating tumor DNA monitoring for early recurrence detection in epithelial ovarian cancer

Read More
DENEB: Development of a new criteria for curability after local excision of pathological T1 colorectal cancer using liquid biopsy

Read More
Analysis of Plasma Cell-Free DNA by Ultradeep Sequencing in Patients With Stage I to III Colorectal Cancer

Read More
A multicenter, prospective observational study to evaluate the impact of circulating tumor DNA guided therapy on patients with colorectal ca

Read More
over 1 year ago
Circulating tumor DNA in stage III colorectal cancer, beyond minimal residual disease detection, towards assessment of adjuvant therapy effi

Read More
Early detection of circulating tumor DNA post-operatively enables discovery of resectable metastatic disease in a patient with colon cancer

Read More
Post-operative ctDNA monitoring in stage I colon cancer: A case report

Read More
ctDNA guiding adjuvant immunotherapy in urothelial carcinoma

Powles T, Assaf ZA, Davarpanah N, et al. Nature.

Read More
Final results of neoadjuvant atezolizumab in cisplatin-ineligible patients with muscle-invasive urothelial cancer of the bladder

Szabados B, Kockx M, Assaf ZA, et al. European Urology.

Read More
Circulating tumor DNA in neoadjuvant treated breast cancer reflects response and survival.

Read More
Treatment response monitoring using a tumor-informed circulating tumor DNA test in an advanced triple negative breast cancer patient: A case

Read More
Reply to Di Cosimo et al.: Advancing circulating tumor DNA for recurrent breast cancer

Read More
Advancing Circulating Tumor DNA for Recurrent Breast Cancer

Read More
A phase II study of talazoparib monotherapy in patients with wild-type BRCA1 and BRCA2 with a mutation in other homologous recombination gen

Read More
Circulating Tumor DNA After Neoadjuvant Chemotherapy in Breast Cancer Is Associated With Disease Relapse

Read More
CIRCULATE-JP GALAXY Nature Medicine Summary

Read More
Early reduction in ctDNA is associated with overall survival (OS) on tebentafusp in previously treated metastatic uveal melanoma patients

Read More
10-Year Anora Clinical Study

Read More
Signatera in Advanced CRC

Read More

Return to Resource Library

© Natera, Inc.

Our Tests
Our Services
Patient Resources
Clinical Resources
- Resource Library
- Provider Portals
Company
Contact

Natera Licenses
IT Security Compliance
Natera Notice of Data Collection for California Residents
Privacy Practices
Privacy Policy
Terms of Use
Sitemap

The tests described have been developed and their performance characteristics determined by the CLIA-certified laboratory performing the test. The tests have not been cleared or approved by the US Food and Drug Administration (FDA). CAP accredited, ISO 13485 certified, and CLIA certified. © 2024 Natera, Inc. All Rights Reserved.